Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Jonathan Mandel

Partner
 
Jonathan Mandel is a Partner at Centerview focused on healthcare services and technology. He has more than 13 years of experience advising healthcare companies on mergers and acquisitions, shareholder activism, equity and debt financings, and other complex strategic issues.

Selected transactions Jonathan has advised on include Oak Street Health’s sale to CVS for $10.6bn, TeamHealth’s sale to Blackstone for $6.1bn, Dassault Systemes acquisition of Medidata for $5.8bn, Cigna's sale of its Medicare Businesses and CareAllies to HCSC $3.7bn, Gainwell’s acquisition of HMS for $3.4bn, MedAssets sale to Pamplona Capital for $2.7bn, The Advisory Board Company’s sale to Optum and Vista Equity for $2.6bn, the Special Committee of the Board of Convey Health’s sale to TPG for $1.1bn, Humana’s $1.1bn divestiture of Concentra to Select Medical and WCAS, Humana’s $600mm Partners in Primary Care joint venture with WCAS, Accolade’s acquisition of 2nd MD for $460mm, Kepro’s sale to CNSI, ERT’s acquisition of Bioclinica, Astorg’s recapitalization of ERT alongside Nordic Capital and Novo, WellSky’s recapitalization with TPG and LGP, and Press Ganey’s sale to Ares and LGP. Selected additional experience includes IPOs for Accolade, Oak Street Health, Health Catalyst, and Cotiviti.

Prior to joining Centerview, Jonathan was a Vice President in the Healthcare Group at Goldman Sachs, and began his career at Fitch Ratings. He received his BA from Vassar College.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Numab Therapeutics AG
Announced: Q2 2024
Value: $1.25 billion
Status: Pending

Lead financial advisor to Numab Therapeutics on its sale of NM-26, a bi-specific antibody, to Johnson & Johnson
View All
New York

Centerview Partners LLC


31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax
London

Centerview Partners UK LLP


1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax
Paris

Centerview Partners France SCS


51 Avenue Hoche


Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC


1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC


555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax





Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC